Reasons for not carrying out stem cell transplantation in patients referred to a transplant unit;Causas por las que no se realiza el trasplante de progenitores hematopoyéticos en pacientes remitidos a una unidad de trasplante

Medicina Clinica

Volumn 121, Issue 11, 2003, Pages 401-404

  Sancho, Juan Manuel ^a   Ribera, Josep María ^a   Oriol, Albert ^a   Batlle, Montserrat ^a   Flores, Alonso ^a   Rodríguez, Lluís ^a   Torrabadella, Marta ^b   Millá, Fuensanta ^a   Feliu, Evarist ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b BANC DE SANG I TEIXITS   (Spain)

Author keywords

Activity registries; Delay; Poor mobilization; Stem cell transplantation

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; APHERESIS; ARTICLE; AUTOTRANSPLANTATION; DECISION MAKING; DETERIORATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOBILIZATION; OUTCOMES RESEARCH; PATIENT ATTITUDE; PATIENT MOBILITY; PATIENT REFERRAL; PATIENT SELECTION; RELAPSE; STATISTICAL SIGNIFICANCE; STEM CELL TRANSPLANTATION; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT PLANNING;

EID: 0242557419     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13052313     Document Type: Article

References (23)

1. Gratwohl A, Baldomero H, Horisberger B, Schmid C, Passweg J, Urbano-Ispizua A for the Accreditation Committee of the European Group for Blood and Marrow Transplantation (EBMT). Current trends in hematopoietic stem cell transplantation in Europe. Blood 2002;100:2374-86.
2. Gratwohl A. The role of the EBMT activity survey in the management of hematopoietic stem cell transplantation. European Group for Blood Marrow Transplantation. Int J Hematol 2002;76 (Suppl 1):386-92.
3. Fouillard L, Labopin M, Gratwohl A, Powles R. Bacigalupo A, Bego G, et al. Outcome of 5651 hematopoietic stem cell transplants for hematological malignancies carried out in Europe in 1993: a reliability study of the registry. Bone Marrow Transplant 2002;30:637-43.
4. Horowitz MM, Loberiza FR, Bredeson CN, Rizzo JD, Nugent ML. Transplant registries: guiding clinical decisions and improving outcomes. Oncology (Huntingt) 2001;15:649-59.
5. Salar A, Martino R, Perea G, Ribera JM, López-Guillermo A, Guardia R, et al. High-dose infusional ifosfamide, etoposide plus methylprednisolone followed by dexamethasone, high-dose ara-C and cisplatinum and autologous stem cell transplantation for refractory or relapsed aggressive non-Hodgkin's lymphoma. Haematologica 2002;87:1028-35.
6. Rozman C, Carreras E, Sierra J, Rovira M, Urbano-Ispizúa A, Marin P, et al. Trasplante de progenitores hematopoyéticos: 20 años de experiencia en la Escuela de Hematología Farreras-Valentí/ Hospital Clínic de Barcelona. Med Clin (Barc) 1997;108:681-6.
7. Tomás FJ, Calvo JM, Gómez-García de Soria V, Pinilla I, Figuera A, Fernández-Rañada JM. Accesibilidad al trasplante de médula ósea en la leucemia aguda mieloblástica. Estudio de 52 pacientes tratados en un solo centro. Med Clin (Barc) 1997;109:12-5.
8. Ribera JM, Oriol A, Esteve J, Guardia R, Bueno J, Brunet S, et al. Feasibility and results of autologous stem cell trasplant (ASCT) in de novo acute myeloid leukemia (AML) in patients over 60 years old. Interim results of the CETLAM99 protocol [abstract]. Proceeding of Forty-fourth annual meeting American Society of Hematology; Philadelphia, 2002.
9. Thomas X, Suciu S, Marie JP, Leone G, Broccia G, Dreyfus F, et al. Feasibility and outcome of autologous stem cell transplantation planned after CR and first consolidation in AML patients aged 61-70 years: Results of the prospective EORTC-GIMEMA AML-13 [abstract]. Proceedings of Forty-fourth annual meeting American Society of Hematology; Philadelphia, 2002.
10. Sierra J, Brunet S, Grañena A, Olivé T, Bueno J, Ribera JM, et al. Feasibility and results of bone marrow transplantation after remission induction and chemotherapy in de novo acute myeloid leukemia. J Clin Oncol 1996;14:1353-63.
11. Rick O, Beyer J, Kingreen D, Kuhl JS, Zingsem J, Huhn D, et al. Successful autologous bone marrow rescue in patients who failed peripheral blood stem cell mobilization. Ann Hematol 2000;79:681-6.
12. Micallef IN, Apostolidis J, Rohatiner AZ, Wiggins C, Crawley CR, Foran JM, et al. Factors which predict unsuccessful mobilisation of peripheral blood progenitors cell following G-CSF alone in patients with non-Hodgkin's lymphoma. Hematol J 2000;1:367-73.
13. Aurlien E, Holte H, Kvaloy S, Jakobsen E, Rusten LS, Kvalheim G. Combination chemotherapy containing mitoguazone, ifosfamide, methotrexate, etoposide (MIME) and G-CSF efficiently mobilize peripheral blood progenitor cells in heavily pre-treated relapsed lymphoma patients. Eur J Haematol 2001;64:14-20.
14. Ketterer N, Salles G, Moullet I, Dumontet C, El-Jaafari-Corbin A, Tremisi P, et al. Factors associated with successful mobilization of peripheral blood progenitor cells in 200 patients with lymphoid malignancies. Br J Haematol 1998;103:235-42.
15. Hass R, Möhle R, Frühauf S, Goldschmidt H. Witt B, Flentje M et al. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 1994;83:3787-94.
16. Sugrue MW, Williams K, Pollock BH, Khan S, Peracha S, Wingard JR, et al. Characterization and outcome of «hard to mobilize» lymphoma patients undergoing autologous stem cell transplantation. Leuk Lymphoma 2000;39:509-19.
17. Laszlo D, Galieni P, Raspadori D, Scalia G, Bigazzi C, Bocchia M, et al. Fludarabine containing-regimens may adversely affect peripheral blood stem cell collection in low-grade non Hodgkin lymphoma patients. Leuk Lymphoma 2000;37:157-61.
18. Navas E, Correa MA, Garzón S, Rubio V, Guzmán JL, Martín E. Movilización de progenitores hematopoyéticos a sangre periférica en pacientes con mieloma múltiple: factores predictivos [resumen]. Actas de XLIV Reunión Nacional de la AEHH; Tarragona, 2002.
19. Boccadoro M, Palumbo A, Bringhen S, Merletti F, Ciccone G, Richiardi L, et al. Oral melphalan at diagnosis hampers adequate collection of peripheral blood progenitors cells in multiple myeloma. Haematologica 2002;87:846-50.
20. Knudsen LM, Rasmussen T, Jensen L, Johnsen HE. Reduced bone marrow stem cell pool and progenitor mobilisation in multiple myeloma after melphalan treatment. Med Oncol 1999;16:245-54.
21. Corso A, Caberlon S, Pagnucco G, Klersy C, Zappasodi P, Alessandrino EP, et al. Blood stem collections in multiple myeloma: definition of a scoring system. Bone Marrow Transplant 2000;26:283-6.
22. Canales MA, Fernández-Jiménez MC, Martín A, Arrieta R, Caballero MD, Diez Quevedo E, et al. Identification of factors associated with poor peripheral blood progenitor cell mobilization in Hodgkin's disease. Haematologica 2001;86:494-8.
23. Arrarás Urdaniz JI, Arias F, Arbizu López JP. Calidad de vida en los pacientes con trasplante de médula ósea. Med Clin (Barc) 1998;110:582-6.